Skip to Main Content
November 11, 2020

Health Law Daily

HHS Secretary Announces US Will Begin Distributing Eli Lilly’s SARS-CoV-2 Antibody Treatment To State Health Departments

  • November 11, 2020

The Washington Post (11/10, Wan) reports that on Tuesday, Administration officials “promised to fairly and swiftly distribute” Eli Lilly’s SARS-CoV-2 antibody treatment, “but the drug’s extremely limited supply and logistical difficulties in administering it could restrict how many people get access to it.” The Post adds that “the federal government has more than 80,000 doses ready for allocation and distribution this week, Health and Human Services Secretary Alex Azar said.”
      Reuters (11/10, Beasley) reports Azar announced the US will begin distributing the “antibody treatment to state health departments.” Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said, “Early treatment may help people avoid disease progression and avoid hospitalization.”
      The Hill (11/10, Weixel) also covers the story.